Posted At Marketwire.com
BY : Marketwire
Rx Processing Corporation (OTC: RXPC), a leading source of low-cost prescription medications for millions of Americans who are under-insured or have no prescription insurance coverage, is relocating and Incorporating in Delaware, a strategic move to become a fully SEC reporting corporation.
Rx Processing Corp. incorporated with the great state of Nevada to give birth to our corporate vehicle that provides affordable prescription drugs and lab testing to US citizens. The Nevada secretary of state and the corporation commission have enabled us to organize properly and compliantly while building a platform for all Americans to achieve affordable health care without prejudice. We value the state of Nevada and look forward to always supporting Nevada residence. The transition to Delaware is to further our commitment to shareholders, by becoming a fully reporting entity in 2006.
Delaware is a strategic move, the state encompasses 60% of all fortune 500 companies. Delaware law is clearly defined to ensure shareholder protection in the United States regulatory environment. The actions of SEC reporting will place our company in an environment that will secure our investors positions in a transparent manor while providing our shareholders market-maker support. The market-maker support Rx Processing Corp is seeking will potentially increase shareholder value exponentially.
Peter Fiorillo commented, "Today with extreme pleasure, I announce Rx Processing Corp., has majority shareholder approval to take these next steps forward to relocate and incorporate in Delaware. My focus as with any large corporate transition is increasing shareholder value, thus we are working diligently to establish our company in Delaware by the end of the year. Shareholders have expressed overwhelming support in this transition to become fully reporting, which opens the door to market-maker support."
About Rx Processing
Rx Processing is positioned to become a market leader in providing prescription drugs, lab tests and drug tests to U.S. citizens, corporations, unions, and members, through FDA-approved patient service centers, for their lab testing and licensed pharmacies in the United States and Canada. The company provides access to approved brand-name and generic medications, as well as over 1,000 lab tests through storefront locations with access to 4,000 FDA-approved patient service centers for their lab testing. Rx Processing estimates that more than 40 million Americans could benefit from the company's low-cost prescription drugs, lab testing and drug screening.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
